RLYB

Rallybio Corporation Common Stock

16.86

USD

-0.25

-1.48%

Sep 24, 15:56 UTC -4

Closed

Pre-Market

16.58

-0.28

-1.66%

Rallybio Corporation Common Stock Profile

About

Rallybio Corporation is a clinical-stage biotechnology company committed to identifying and accelerating the development of therapies for patients with severe and rare diseases. Rallybio Corporation is headquartered in New Haven, Connecticut.

Info & Links

CEO

Stephen Uden

Headquarters

234 CHURCH STREET, SUITE 1020
NEW HAVEN, CT 06510, UNITED STATES

Auditor

Deloitte & Touche LLP

Share holders

Employees

Rallybio Corporation Common Stock Statistics

Valuation Measures

Market Capitalization²

88.08M

Enterprise Value

-4.77M

Enterprise Value/EBITDA(ttm)

0.17

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

104.72

Price to Book(mrq)

0.95

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

75.00%

Operating Margin(ttm)

-3531.00%

Profit Margin(ttm)

253.49%

Return on Equity(ttm)

-40.53%

Return on Invested Capital(ttm)

45.05%

Return on Assets(ttm)

-38.13%

Income Statement

Revenue(ttm)

646.00K

Revenue Per Share(ttm)

0.12

Gross Profit(ttm)

646.00K

EBITDA(ttm)³

-27.95M

Net Income Available to Common(ttm)

45.55M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

-0.85

52-Week Change

256.78%

S&P 500 52-Week Change

19.38%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

5.31M

Dividend Yield

0.00%

Float⁴

4.76M

% Held by Insiders

10.30%

% Held by Institutions

90.34%

Balance Sheet

Total Cash(mrq)

92.85M

Total Cash Per Share(mrq)

17.48

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

27.26%

Quick Ratio(mrq)

27.26%

Book Value Per Share(mrq)

17.81

Cash Flow

Operating Cash Flow Per Share(ytd)

6.54

Free Cash Flow(ytd)

37.94M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.